CPAP Observance During the COVID-19 (SARS-CoV-2) Pandemic

NCT04775966•University Hospital, Montpellier

Summary

The hypothesis of this work is that the COVID 19 pandemic and the associated lockdowns are likely to modify the adherence to positive airway pressure (PAP) treatments among patients with sleep apnea. Identifying these patients and identifying adherence "trajectories" over time would help mobilize human and telemedicine resources on the patients most in need.

Detailed Description

The primary objective of this study is to compare PAP adherence during lockdowns in 2020 with the corresponding weeks during 2019.

Eligibility

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•patient treated/monitored by the Adene group
•treated for sleep apnea syndrome (i.e., an initial apnoea hypopnea index (iAHI) ≥ 30/h or iAHI ≥ 15/h (and more than 10/h respiratory-effort-related arousal or cardio-metabolic/respiratory comorbidities) associated with symptoms from among sleepiness, tiredness, snoring, headaches, hypertension, reduced vigilance, libido disorders, nocturia, choking or suffocation during sleep, daytime tiredness)
•Positive airway pressure (PAP)-treated for at least 4 months before January 1, 2019
•continuous PAP during 2019
•continuous PAP during 2020
•acceptance of PAP telemonitoring with consent given for data collection and data anonymization

Exclusion Criteria

•less than 360 daily PAP tele-monitored data per year for 2019
•less than 360 daily PAP tele-monitored data per year for 2020

Locations (1)

Adene Group

Montpellier, France

Key Dates

Start Date

January 15, 2021

Primary Completion Date

February 15, 2021

Completion Date

February 15, 2021

Last Updated

March 22, 2022

Enrollment

8,477

ACTUAL participants

Conditions

Sleep Apnea Syndromes

Apnea, Stroke and Incident Cardiovascular Events

NCT04399200

StrokeSleep-disordered Breathing+4 more

View study

ENROLLING_BY_INVITATIONNA

Fascial Mobilization Along the Vagus Nerve and Its Effects on Acute Physiological Parameters in Obstructive Sleep Apnea

NCT07169058

Obstructive Sleep Apnea Syndromes

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: March 22, 2022Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

CPAP Observance During the COVID-19 (SARS-CoV-2) Pandemic

Inclusion Criteria

Exclusion Criteria

Apnea, Stroke and Incident Cardiovascular Events

Fascial Mobilization Along the Vagus Nerve and Its Effects on Acute Physiological Parameters in Obstructive Sleep Apnea

Adverse Long-term Consequences of Sleep Disordered Breathing: The Ottawa Hospital (TOH) Sleep Database

Janus Feasibility Study

Evaluation of An Optical Measurement Algorithm Combined With Patient and Provider Input to Reduce Mask Exchanges During Initial Positive Airway Pressure Therapy

Evaluation of the Effects of Hypoglossal Nerve Stimulation in Humans With Obstructive Sleep Apnea